Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-039031
Filing Date
2023-05-12
Accepted
2023-05-12 16:15:47
Documents
47
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0323_citiuspharma.htm   iXBRL 10-Q 540658
2 PATENT AND TECHNOLOGY LICENSE AGREEMENT, DATED MAY 14, 2014, BETWEEN NOVEL ANTI- f10q0323ex10-1_citiuspharma.htm EX-10.1 146072
3 CERTIFICATION f10q0323ex31-1_citiuspharma.htm EX-31.1 10611
4 CERTIFICATION f10q0323ex31-2_citiuspharma.htm EX-31.2 10316
5 CERTIFICATION f10q0323ex32-1_citiuspharma.htm EX-32.1 5592
  Complete submission text file 0001213900-23-039031.txt   3444944

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ctxr-20230331.xsd EX-101.SCH 47827
7 XBRL CALCULATION FILE ctxr-20230331_cal.xml EX-101.CAL 28461
8 XBRL DEFINITION FILE ctxr-20230331_def.xml EX-101.DEF 164458
9 XBRL LABEL FILE ctxr-20230331_lab.xml EX-101.LAB 355141
10 XBRL PRESENTATION FILE ctxr-20230331_pre.xml EX-101.PRE 177321
41 EXTRACTED XBRL INSTANCE DOCUMENT f10q0323_citiuspharma_htm.xml XML 297969
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 23915916
SIC: 2834 Pharmaceutical Preparations